Navigation Links
Dr. Karol Sikora Accepts Appointment to MEI Healthcare Group's Board of Directors
Date:7/19/2011

CORAL SPRINGS, Fla., July 19, 2011 /PRNewswire/ -- MEI Healthcare Group, a leading provider of healthcare strategies and equipment solutions to medical facilities around the world, announced today that Dr. Karol Sikora has accepted an appointment to the company's board of directors. Sikora is the medical director of CancerPartnersUK, the largest independent cancer network in the UK, and is dean of medicine at the University of Buckingham, Britain's first independent medical school. Sikora was previously Chief of the World Health Organization's cancer programme and served as professor and chairman of the Department of Cancer Medicine at Imperial College School of Medicine. He is currently an honorary consultant oncologist at Hammersmith Hospital in London, where he served as clinical director for cancer services for 12 years, and is a fellow of Corpus Christi College in Cambridge.

"We are delighted to have Professor Sikora as a member of our board. His vision and experience on the international stage in both the public and private sectors will be a major asset to the MEI Healthcare Group," said MEI board chair Dr. Arthur Porter.

While serving at Hammersmith Hospital, Sikora chaired that facility's fundraising campaign, an appeal that raised 8m pounds Sterling to construct the Cancer Centre at Hammersmith.  Later, he became vice president for Pharmacia Corporation and managed the company's global clinical research for oncology. He is currently an adviser to the World Health Organization, the International Atomic Energy Agency (IAEA) and is a member of the UK Health Department's Expert Advisory Group on Cancer.

Sikora has published more than 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook now in its fifth edition and, most recently, The Economics of Cancer Care.  He is on the editorial board of several journals and is the founding editor of Gene Therapy and Cancer Strategy.

MEI provides business development, capital equipment funding strategies and growth consulting services to physicians, hospitals and healthcare systems worldwide.

About MEI Healthcare Group

Headquartered in Coral Springs, Fla., MEI is a comprehensive healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions. MEI and its subsidiaries, MEI Development Corporation, MEI Healthcare Capital, MEI Informatics, MEI Healthcare International and MEI Healthcare Foundation, offer its clients more than 40 years of healthcare business experience and the value-added benefits of its strategic alliances. For more information, visit http://www.mei.com

CONTACT:
Tyler Lecceadone
SeyferthPR
1-800-435-9539
Lecceadone@seyferthpr.com


'/>"/>
SOURCE MEI Healthcare Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Karolinska Development to Divest Portfolio Company
2. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
3. Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment
4. Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR)
5. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. FDA Accepts Endo Pharmaceuticals Complete Response for New Formulation of OPANA® ER
9. FDA Formally Accepts Dune Medicals MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
10. Paul Meade Accepts Invitation to Speak at AACE Annual Meeting
11. FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
Breaking Medicine News(10 mins):